Morphologic characteristics of varicose veins: possible role of metalloproteinases  by Woodside, Kenneth J et al.
Morphologic characteristics of varicose veins:
Possible role of metalloproteinases
Kenneth J. Woodside, MD, Mingdao Hu, MD, Ann Burke, MS, Maki Murakami, MD, Lori L. Pounds,
MD, Lois A. Killewich, MD, PhD, John A. Daller, MD, PhD, and Glenn C. Hunter, MD, Galveston, Tex
Background: Although varicose veins are a common cause of morbidity, etiologic factors predisposing to dilatation,
elongation, and tortuosity of the saphenous vein and its tributaries are poorly understood. We compared histologic
features of normal and varicose saphenous veins and investigated the role of enzyme or inhibitor imbalance in
development of varicosities.
Methods: Eight normal and 10 varicose (C2,3EP,SASPR,O) vein segments were used for this analysis. Matrix metallopro-
teinase (MMP) expression and activity were analyzed with Western blotting and zymography. Venous architecture and
protein localization were determined with histology and immunohistochemistry.
Results: Western blot analysis demonstrated the presence of MMP- 1, MMP-2, MMP-9, and MMP-12, as well as small
quantities of tissue inhibitor of metalloproteinases (TIMP)–1 and TIMP-2 in protein isolates from normal and varicose
veins. Both vein types demonstrated MMP-2, MMP-9, and MMP-12 activity by gelatin zymography, although varicose
vein expressed less MMP-9 activity than normal vein did. Compared with normal veins, changes in varicose veins were not
uniformly distributed along the circumference; areas of intimal thickening were often interspersed with focal areas of
dilatation. Fragmentation of elastic lamellae and loss of circular and longitudinal muscle fibers were evident in the
varicosities. Focal aggregates of macrophages were detected within the media and adventitia of both normal and varicose
veins. MMP-1 and MMP-9 were expressed in both types of vein segments; however, their immunohistochemical
localization was distinctly different. In normal vein, endothelial cells, occasional smooth muscle cells (SMC), and
adventitial microvessels expressed MMP-1, whereas its expression was localized to fibroblasts, SMC, and endothelial cells
throughout involved portions of varicose veins. MMP-9 was localized to endothelial cells, medial SMC, and adventitial
microvessels in both normal and varicose veins, although varicose veins demonstrated increased medial smooth muscle cell
staining. MMP-12 was found in SMC and fibroblasts in both normal and varicose veins. Neither TIMP-1 nor TIMP-2
were detected with immunohistochemistry in any specimens examined.
Conclusions: There are distinct differences in the structural architecture and localization of MMP expression in normal
and varicose veins. Although the changes observed are not sufficiently definitive to enable a causal relationship, they do
suggest a possible mechanism for the alterations in matrix composition observed between normal and varicose veins. (J
Vasc Surg 2003;38:162-9.)
With a prevalence of 10% to 50% in the general popu-
lation, varicose veins are an important cause of morbidity.
Risk factors for varicose veins include increasing age, female
gender, dietary factors, obesity, physical activity, standing
occupations, connective tissue abnormalities, and genetic
predisposition.1,2 The concept of venous dilation second-
ary to valvular incompetence, with subsequent venous hy-
pertension, as the major cause of varicose veins has been
challenged. Loss of tone due to structural weakness of the
venous wall resulting from imbalance in synthesis and deg-
radation of matrix proteins has received increasing atten-
tion.3-5 Because matrix metalloproteinases (MMP) and
their inhibitors, tissue inhibitors of metalloproteinases
(TIMP), are important in synthesis and degradation of
extracellular matrix,6 we sought to determine the expres-
sion of various MMP and TIMP in normal and varicose
saphenous veins.
METHODS
Materials. Antibodies used for immunohistochemis-
try included anti-human MMP-1 monoclonal antibody
(1:200 dilution; Oncogene Research Products, Cam-
bridge, Mass), anti-human MMP-2 monoclonal antibody
(1:400 dilution; NeoMarkers, Fremont, Calif), anti-human
MMP-3 monoclonal antibody (1:2000 dilution; NeoMar-
kers), rabbit anti-human MMP-9 polyclonal antibody (1:
5000 dilution; Calbiochem, La Jolla, Calif), rabbit anti-
human MMP-12 polyclonal antibody (1:5000 dilution;
Chemicon, Temecula, Calif), anti-human TIMP-1 mono-
clonal antibody (1:200 dilution; NeoMarkers), anti-human
TIMP-2 monoclonal antibody (1:200 dilution; Vector
Laboratories, Burlingame, Calif), anti-human factor VIII–
related antigen monoclonal antibody (1:200 dilution; Bio-
Genex Laboratories, San Ramon, Calif), anti-human endo-
thelial nitric oxide synthase (eNOS) monoclonal antibody
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(1:500 dilution; BD Transduction Laboratories, San Di-
ego, Calif), and anti-human -smooth muscle actin and
CD68 (macrophage) monoclonal antibodies (1:500 dilu-
tion; DAKO Corp, Carpenteria, Calif). Anti-human mono-
clonal antibodies to MMP-1, MMP-2, MMP-9, TIMP-1,
and TIMP-2 used for Western blot analysis (1:100-1:500
dilutions) were obtained from Oncogene, and goat anti-
human MMP-12 polyclonal antibody (1:200 dilution) was
obtained from Santa Cruz Biotechnology (Santa Cruz,
Calif).
Tissue procurement. Segments of primary and sec-
ondary C2,3EP,SASPR,O varicose greater saphenous vein
and its tributaries (n  10) from below the knee were
obtained from patients undergoing vein ligation and strip-
ping. Normal greater saphenous vein segments (n  8)
from below the knee were obtained from patients under-
going revascularization for trauma or arterial occlusive dis-
ease. The tissues were collected at surgery, with minimal
handling and trauma, and were promptly placed in either
10% phosphate-buffered formalin or Streck tissue fixative
solution (Streck Laboratories, Omaha, Neb) for histologic
analysis and immunohistochemistry or were snap-frozen
for protein extraction. Tissue acquisition and subsequent
use were approved by the University of Texas Medical
Branch Institutional Review Board.
Histologic analysis and immunohistochemis-
try. Paraffin-embedded and frozen sections, and positive
and negative control specimens, were stained with hema-
toxylin-eosin or pentachrome stain for histologic analysis
and with antibodies to appropriate antigens for immuno-
histochemistry. In brief, venous samples were fixed in either
10% phosphate-buffered formalin or Streck tissue fixative
overnight and processed for paraffin embedding. Four-
micrometer sections were cut and dried in a 60°C oven
overnight. The slides were deparaffinized, rehydrated, and
processed for immunohistochemistry on an automated im-
munostainer (Optimax; BioGenex, San Ramon, Calif). An-
tigen retrieval was performed with BioGenex Antigen Re-
trieval Citra Plus at pH 6.0 for 10 minutes at 100°C. The
slides were rinsed in distilled water, treated for 5 minutes
with 0.9% hydrogen peroxide in 100% methanol to remove
endogenous peroxidase activity, then predigested in
0.0025% protease in phosphate-buffered saline solution
(PBS) at pH 7.6 for 30 minutes at room temperature. The
slides were then rinsed in buffer and incubated with normal
serum for 30 minutes before adding the appropriate anti-
body dilution. Each antibody was incubated at room tem-
perature for 1 hour, washed, and detected with the appro-
priate Vector Elite peroxidase-DAB kit according to the
manufacturer’s directions. The slides were counterstained
with hematoxylin. Endothelial cell identity was verified
with staining for factor VIII antigen and, in selected cases,
eNOS. Macrophage identity was verified with staining for
CD68. Sections of human placenta and pancreatic adeno-
carcinoma were used as positive controls for MMP and
TIMP antibodies, respectively. Primary antibodies were
omitted for negative control specimens. Four or five sepa-
rate sections from each specimen were examined by three
blinded observers
Protein isolation. The vein samples were weighed,
and protein was extracted from vein samples with radio-
immuno-precipitation buffer (50 mmol/L of Tris hydro-
chloride, 150 mmol/L of sodium chloride, 1% NP40, 0.5%
sodium deoxycholate, 0.1% sodium dodecylsulfate (SDS),
100 mmol/L of phenylmethylsulfonyl fluoride, and pro-
tease inhibitor cocktail tablets). Protein concentrations
were determined with a protein assay kit (Bio-Rad, Her-
cules, Calif), in which protein absorbance is measured with
spectrophotometry at 595 nm.
Western blot analysis. Protein (50 g) was subjected
to 10% BT gel electrophoresis and transferred to a nitrocel-
lulose membrane (Invitrogen, Carlsbad, Calif). Equal load-
ing of protein was confirmed with staining with Coomassie
blue (Bio-Rad) and blotting for -actin. The membrane
was blocked with 5% dry milk and 0.05% Tween (Sigma, St
Louis, Mo) in triethanolamine-buffered saline solution and
incubated with the appropriate antibody. Filters were
washed and incubated with secondary antibody. Kodak film
was exposed to the filters, and relative band strength was
determined with densitometry (Alpha Innotech, San Lean-
dro, Calif).
Zymography. Protein was mixed (1:1) with Novex
tris-glycerine sodium dodecylsulfate buffer (Invitrogen)
and incubated at room temperature for 10 minutes. The
samples were loaded into a Novex 10% Zymogram gelatin
gel (Invitrogen) and subjected to electrophoresis. The pro-
tein was renatured, Zymogram developing buffer (Invitro-
gen) was added, and the gel was incubated at 37°C for 6
hours. The gel was then stained with Coomassie blue
R-250 for 30 minutes, then destained with Coomassie
R-250 destain solution.
Statistical analysis. Data are expressed as mean 
SEM, and were compared with the unpaired t test.
RESULTS
Demographic data for patients from whom tissue was
obtained for analysis are listed in the Table. Of no surprise,
more women than men underwent treatment for varicose
veins, and a greater number of men underwent bypass graft
procedures. No patients in either group were obese.
Western blot analysis demonstrated the presence of
MMP-1, MMP-2, MMP-9, and MMP-12 in protein iso-
lated from both normal and varicose veins (Fig 1). There
was a trend toward higher MMP-12 levels in normal vein
compared with varicose vein by densitometry. Only small
quantities of TIMP-1 or TIMP-2 protein were detected in
either normal or varicose vein. Once normalized to -actin,
the slight differences in MMP or TIMP levels were not
statistically significant for any of the proteins analyzed with
Western blotting. Both normal and varicose veins demon-
strated MMP-2, MMP-9, and MMP-12 activity by gelatin
zymography (Fig 2). In particular, normal vein demon-
strated more MMP-9 activity than varicose vein did. Both
normal and varicose veins demonstrated significant variabil-
ity between individual specimens with both Western blot-
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ting and zymography, preventing meaningful statistical
analysis.
By histologic analysis, normal saphenous vein was char-
acterized by an endothelial layer overlying the media, com-
posed predominantly of elastic tissue fibers, circular and
longitudinal smooth muscle bundles, and connective tis-
sue. Focal areas of intimal thickening were noted in some
specimens (Fig 3). The adventitia was composed of colla-
gen, fibroblasts, smooth muscle cells (SMC), and microves-
sels. In contrast to normal vein, varicose vein demonstrated
regional variability in wall thickness (Fig 3, D). In some
regions, varicose vein demonstrated collagen intimal
plaques beneath the endothelial lining, with fragmentation
of the elastic lamallae and disorganization of the medial
circular and longitudinal smooth muscle bundles. The ad-
ventitia showed an increase in SMC, fibroblasts, and colla-
gen. In other areas, varicose vein walls were attenuated,
with a decrease in cellular and matrix elements.
Occasional foci of macrophages were detected in the
media and adventitia by immunohistochemistry in both
normal and varicose veins. MMP-1, MMP-9, and MMP-12
were found in both normal and varicose veins, although
their distribution was different. MMP-1 localized to the
endothelium, SMC, and adventitial microvessels in normal
vein (Fig 4). In varicose vein, MMP-1 was expressed in the
endothelium and more diffusely throughout the media in
SMC, fibroblasts, and the rare adventitial microvessel.
MMP-2 was not detected by immunohistochemistry in
either normal or varicose vein, despite adequate staining of
positive control vein specimens. MMP-9 localized to endo-
thelial cells, medial SMC, and adventitial microvessels in
both normal and varicose veins, although varicose veins
demonstrated increased medial SMC staining. MMP-12
was detected in SMC and fibroblasts in both normal and
varicose veins. Neither TIMP-1 nor TIMP-2 was detected
by immunohistochemistry in normal or varicose veins (Fig
5). Positive and negative control specimens for all immu-
nohistochemistry stained appropriately.
DISCUSSION
Etiologic factors responsible for structural changes ob-
served in varicose veins are poorly understood. Venous
hypertension due to valvular insufficiency may not be pri-
marily responsible for the structural changes observed in
these veins,7-9 as previously believed. However, molecular
mechanisms linking the hemodynamic changes of venous
hypertension and structural changes in the walls of varicose
veins remain unclear. Recent studies suggest that the bal-
ance of vascular SMC proliferation and extracellular matrix
deposition and degradation may be perturbed, resulting in
loss of mechanical wall strength, venous dilatation, and
venous elongation.3-5,7-11 Venturi et al10 demonstrated a
decrease in desmosine and isodesomsine and elastin-colla-
gen ratio in varicose versus normal veins. Michiels et al11
showed that hypoxia-induced leukocyte activation results
in free radical release, protease activation, and, as a conse-
quence, extracellular matrix degradation in varicose veins.
In addition, they demonstrated that hypoxia activates en-
dothelial cells to secrete growth factors and stimulate SMC
proliferation and extracellular matrix synthesis. These stud-
ies suggest that perturbations in both synthesis and degra-
dation of the structural elements occur in varicose vein
segments.
Vascular wall remodeling depends on the activity of
macrophages, SMC, endothelial cells, and fibroblasts. Ex-
Fig 2. Zymography demonstrates MMP-2, MMP-9, and
MMP-12 activity in normal and varicose veins.
Table I. Patient demographics
Normal vein Varicose vein
No. of patients 8 10
Age (y) 58  7 47  5






Renal insufficiency 1 0
Fig 1. Western blotting demonstrates expression of MMP-1,
MMP-2, MMP-9, MMP-12, TIMP-1, and TIMP-2 protein in
normal and varicose veins in 10 patients.
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Fig 3. Histochemical staining of section of normal saphenous vein (A) and varicose vein (B) shows disorganization of
intimal and medial connective tissue elements in the varicose vein (hematoxylin-eosin; original magnification 100).
Pentachrome staining of normal vein (C) and varicose vein (D) demonstrates normal (black arrow) and attenuated
(white arrow) regions of varicose vein wall (pentachrome; original magnification 40). Elastic tissue stained black,
muscle stained maroon, and extracellular matrix stained yellow. High-power view shows well-organized components of
the wall of a normal vein (E) and disorganization in a varicose vein (F), with an area of intimal thickening (arrow)
(pentachrome; original magnification 200).
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Fig 4. Immunohistochemical staining (DAB 200) of representative sections of normal and varicose vein for matrix
metalloproteinase (MMP). Brown-staining endothelial cells (SMC) and microvessels (arrows) expressing MMP-1 in
normal vein (A), compared with more diffuse staining in varicose vein (B). Absence of staining for MMP-2 in both
normal (C) and varicose (D) veins. Brown-staining adventitial microvessels (black arrows), SMC (white arrow), and
endothelium (arrowhead) express MMP-9 in normal vein (E) and varicose vein (F) vein. Brown-staining SMC and
fibroblasts express MMP-12 in normal vein (G) and varicose vein (H).
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tracellular matrix deposited by SMC and fibroblasts is de-
graded by macrophage-secreted enzymes, eg, MMP. MMP
degrade collagen, elastin, fibronectin, laminin, and other
components of the extracellular matrix with varying de-
grees of efficacy.6
Consistent with these observations, our histologic find-
ings of normal and varicose vein segments demonstrate
areas of intimal thickening interspersed with focal areas of
dilatation, associated with fragmentation of the elastic la-
mellae and loss of circular and longitudinal muscle fibers. In
addition to local variability in microscopic structure,
Travers et al8 and Gillespie et al9 demonstrated regional
differences in extracellular matrix content and MMP activ-
ity between proximal and distal varicose vein segments.
We detected differences in distribution of MMP-1 and
MMP-9 between normal and varicose veins by immunohis-
tochemistry. Lumen endothelial cells, SMC, and fibroblasts
in both types of specimens expressed these MMP. Endo-
thelial cells lining the adventitial microvessels in normal
vein were more numerous and had increased expression of
these MMP. Whether these differences merely reflect the
fewer number of adventitial microvessels in varicosities or
whether the paucity of microvessels in the attenuated seg-
ments has a role in the cause of varicosities is under inves-
tigation. We did not detect MMP-2, TIMP-1, or TIMP-2
in any tissues examined by immunohistochemistry.
Whether MMP-2 and TIMP-1 and TIMP-2 are truly ab-
sent in varicose veins was not established with certainty in
our study, although positive control specimens stained
appropriately with the same antibodies. The relative ab-
sence of MMP-2 confirms the observations of Badier-
Commander et al.3 However, it is possible that the meth-
ods of tissue preservation altered protein epitope
confirmation, that only trace amounts of these proteases
and their inhibitors are present, or that the affinity of our
particular antibody is insufficient to detect the amount of
protein present in the tissue. Western blot analysis demon-
strated MMP-1, MMP-2, MMP-9, MMP-12, TIMP-1,
Fig 5. Immunohistochemical staining (DAB 200) of representative sections of normal and varicose vein for tissue
inhibitor of metalloproteinase (TIMP)–1 (A, B) and TIMP-2 (C, D) demonstrates absence of detectable protein
expression.
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and TIMP-2 in both normal and varicose veins. Unlike
other authors,3 we were unable to confirm an overall im-
balance in MMP and TIMP production in varicose veins
compared with normal veins, perhaps because of the inher-
ent variability of the disease process. Another reason for the
differences between our observations and those of Badier-
Commander et al3 may be that we used both primary and
secondary varicosities, whereas they used only primary var-
icose vein segments. The structural differences between
primary and secondary varicose veins could explain the
differences in MMP expression between the two studies.
The relatively small number of patients in each group did
not allow us to independently analyze the differences be-
tween primary and secondary varicosities.
Gelatin zymography showed activity of MMP-2,
MMP-9, and MMP-12, with more MMP-9 activity in
normal veins than varicose veins. The differences in
MMP-9 levels and activity detected with Western blot
analysis and zymography, respectively, may be explained by
differences in TIMP levels or other factors modulating
enzyme activity. Alternatively, the differences in tissue pro-
tein levels or enzyme activity may be less important than
enzyme distribution within diseased venous segments. The
specific cellular location and activity of these proteases and
their inhibitors may have more influence on development,
extent, and severity of varicosities, and may account for the
inherent variability of the disease. Consistent with our
results, Parra et al12 demonstrated decreased MMP-2 and
increased TIMP-1 with Western blotting at the saphe-
nofemoral junction in patients with varicose veins. These
changes were associated with a decrease in proteolytic
activity. However, they did not find any immunohisto-
chemical differences in MMP-2, MMP-9, and TIMP-1
expression when comparing normal and varicose veins.12
Although we found similar expression of MMP and
TIMP with Western blot analysis between groups, zymog-
raphy revealed increased MMP-9 activity in normal vein
compared with varicose vein. In contrast, George et al13
demonstrated increased MMP-2 activation and MMP-9
expression in response to surgical injury of the saphenous
vein wall. These results are somewhat surprising, because it
would have been expected that a similar regulatory mech-
anism is responsible for extracellular matrix remodeling in
response to both surgical and hemodynamic trauma. It is
possible that the sustained hemodynamic trauma in varicos-
ities, compared with the acute nature of surgical injury,
accounts for these differences. MMP are secreted in an
inactive form, with proteolytic cleavage of the zymogen
required for activation14; therefore cellular localization of
actual enzyme activity may need to be determined. The
observation that venous wall dilatation is focal in some areas
and diffuse in other areas of the varicose vein may be the
result of such differences in local activation of MMP in
specific regions of the vein.
In view of the fragmentation of the elastic tissue lamel-
lae observed at histologic analysis, we were particularly
interested in expression and activity of MMP-12 (macro-
phage elastase) in these venous samples. We detected
MMP-12 with Western blotting, zymography, and immu-
nohistochemistry in both normal and varicose vein seg-
ments. The absence of appreciable differences in MMP-12
between normal and varicose veins may reflect the small
number of macrophages or lower levels of elastase activa-
tion in these specimens.
An imbalance of MMP and TIMP activity has been
proposed as a mechanism for accumulation of extracellular
matrix in varicose veins. TIMP-1, an inhibitor of most
MMP, is induced by cytokines and soluble factors, eg,
transforming growth factor–, platelet-derived growth fac-
tor, angiotensin II, and prostaglandins.6,15-18 TIMP-2 is
constitutively expressed paired with MMP-2.6,15 Whereas
other investigators3 found increased TIMP-1 levels in var-
icose veins, our study demonstrated only weak TIMP-1 and
TIMP-2 levels by Western blot analysis, and we did not
detect either protein by immunohistochemistry despite
appropriate staining of control specimens. Whether MMP
activity in varicose veins is regulated by other inhibitory
proteases, in addition to TIMP, or whether expression of
TIMP-1 and TIMP-2 is below the threshold of detection
with the antibodies used is presently under investigation.
In conclusion, we have demonstrated the variable wall
structure of varicose veins, with areas of attenuation and
dilatation interspersed with focal areas of intimal thicken-
ing. Fragmentation of the elastic lamellae and loss of the
circular and longitudinal muscle bundles are characteristic
histologic features. Differences in expression and, probably
more important, microscopic localization of MMP and
TIMP between normal and varicose veins, may explain the
variability of the disease within a given vein segment. Fur-
ther studies are ongoing to more clearly define the role of
MMP and their inhibitors in determining distribution of
focal or diffuse dilatation within different types of varicose
veins.
We thank Liz Cook and Karen Martin for assistance
with manuscript preparation.
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